Haley Naik, MD

Title(s)Associate Professor, Dermatology
SchoolSchool of Medicine
Address2340 Sutter Street, #S429
San Francisco CA 94115
ORCID ORCID Icon0000-0003-2760-3904 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Harvard Medical SchoolM.D.2007
    Stanford Hospital and ClinicsInternship2008
    Harvard Combined Program in DermatologyDermatology Residency2011
    Duke UniversityM.H.Sc.2014
    National Institutes of HealthClinical Research Fellowship2015
    University of California, San Francisco, CA2019Diversity, Equity, and Inclusion Champion Training
    Collapse Awards and Honors
    University of California, San Francisco2017CTSI KL2 Award
    Dermatology Foundation2015Medical Dermatology Career Development Award
    American Skin Association2015Research Grant in Inflammatory Skin Diseases
    National Psoriasis Foundation2014Discovery Grant
    American Academy of Dermatology2013Academic Dermatology Leadership Program
    Council for International Exchange of Scholars2001US-UK Fulbright Scholarship
    Barry Goldwater Scholarship and Excellence in Education Foundation2000Barry M. Goldwater Scholarship

    Collapse Overview 
    Collapse Overview
    Hidradenitis Suppurativa (HS) is a prevalent and debilitating disease predominating in women and minorities. Despite its prevalence and morbidity, the biology of HS is poorly understood, thus limiting the development of effective therapies. Rigorous investigation of cutaneous dysbiosis (abnormal microbial colonization of skin) and immune dysregulation associated with HS is urgently needed to understand their roles in HS pathogenesis, and to guide the development of novel therapeutic approaches for this devastating disease.

    Dr. Naik is trained both in dermatology and in clinical investigative methods. She is an emerging leader in immune-mediated skin disease research. Her research team's primary goals are to elucidate the mechanisms underlying HS, and to better understand the impact of HS on patients. Dr. Naik also provides specialty care for patients suffering from HS in the context of the UCSF Hidradenitis Suppurativa Clinic which she established.

    Collapse Research 
    Collapse Research Activities and Funding
    Microbial Shifts and Immune Dysregulation in Hidradenitis Suppurativa Pathogenesis
    NIH K23AR074531Aug 1, 2019 - May 31, 2024
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Featured Content 
    Collapse Twitter

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Global consensus process to establish a core dataset for hidradenitis suppurativa registries. Br J Dermatol. 2024 Mar 15; 190(4):510-518. Wainman HE, Chandran NS, Frew JW, Garg A, Gibbons A, Gierbolini A, Horvath B, Jemec GB, Kirby B, Kirby J, Lowes MA, Martorell A, McGrath BM, Naik HB, Oon HH, Prens E, Sayed CJ, Thorlacius L, Van der Zee HH, Villumsen B, Ingram JR. PMID: 37976235.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. Balancing Ertapenem Therapy in Recalcitrant Hidradenitis Suppurativa With Antibiotic Stewardship. JAMA Dermatol. 2024 Mar 01; 160(3):319. Naik HB. PMID: 38353969.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. The Global Hidradenitis Suppurativa Atlas (GHiSA) Methodology: Combining Global Proportions in a Pooled Analysis. Dermatology. 2024 Feb 14. Bouazzi D, Andersen RK, Vinding GR, Medianfar CE, Nielsen SM, Saunte DML, Chandran NS, van der Zee HH, Zouboulis CC, Benhadou F, Villumsen B, Alavi A, Ibekwe PU, Hamzavi IH, Ingram JR, Naik HB, Garg A, Boer J, Christensen R, Jemec GBE. PMID: 38354718.
      View in: PubMed   Mentions:    Fields:    
    4. Tertiary lymphoid structures sustain cutaneous B cell activity in hidradenitis suppurativa. JCI Insight. 2024 Feb 08; 9(3). Lowe MM, Cohen JN, Moss MI, Clancy S, Adler JP, Yates AE, Naik HB, Yadav R, Pauli M, Taylor I, McKay A, Harris H, Kim E, Hansen SL, Rosenblum MD, Moreau JM. PMID: 38113104; PMCID: PMC10967391.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    5. Longitudinal remote monitoring of hidradenitis suppurativa: a pilot study. Br J Dermatol. 2024 Jan 23; 190(2):274-276. Fonjungo FE, Barnes LA, Cai ZR, Naik HB, Eid ES, Aleshin MA, Nava V, Johnson T, Chren MM, Linos E. PMID: 37823362; PMCID: PMC10805523.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Access to dermatologic care and provider impact on hidradenitis suppurativa care: global survey insights. Int J Womens Dermatol. 2024 Mar; 10(1):e130. Rinderknecht FB, Naik HB. PMID: 38240011; PMCID: PMC10796138.
      View in: PubMed   Mentions:
    7. Female sex and younger age are associated with hidradenitis suppurativa diagnostic delay. Int J Womens Dermatol. 2023 Dec; 9(4):e114. Rinderknecht FB, Naik HB. PMID: 37927367; PMCID: PMC10619890.
      View in: PubMed   Mentions:
    8. Outcome Measures for the Evaluation of Treatment Response in Hidradenitis Suppurativa for Clinical Practice: A HiSTORIC Consensus Statement. JAMA Dermatol. 2023 11 01; 159(11):1258-1266. Mastacouris N, Tannenbaum R, Strunk A, Koptyev J, Aarts P, Alhusayen R, Bechara FG, Benhadou F, Bettoli V, Brassard A, Brown D, Choon SE, Coutts P, da Silva DLF, Daveluy S, Dellavalle RP, Del Marmol V, Emtestam L, Gebauer K, George R, Giamarellos-Bourboulis EJ, Goldfarb N, Hamzavi I, Hazen PG, Horváth B, Hsiao J, Ingram JR, Jemec GBE, Kirby JS, Lowes MA, Marzano AV, Matusiak L, Naik HB, Okun MM, Oon HH, Orenstein LAV, Paek SY, Pascual JC, Fernandez-Peñas P, Resnik BI, Sayed CJ, Thorlacius L, van der Zee HH, van Straalen KR, Garg A. PMID: 37755725.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. Patient-reported influences on COVID-19 vaccine acceptance and hesitancy in people with hidradenitis suppurativa. Br J Dermatol. 2023 08 24; 189(3):351-353. Williams JC, Alhusayen R, Guilbault S, Ingram JR, Lowes MA, Yannuzzi CA, Naik HB. PMID: 37210215; PMCID: PMC10449532.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    10. Increased Doses of Adalimumab are Associated With Clinical Improvement of Hidradenitis Suppurativa. J Drugs Dermatol. 2023 06 01; 22(6):615-618. Williams J, Guzik C, Wadhera A, Naik H. PMID: 37276155.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    11. The Critical Need for Reliable and Clinically Meaningful Outcome Measures for Hidradenitis Suppurativa. JAMA Dermatol. 2023 06 01; 159(6):581-583. Naik HB. PMID: 37099321.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    12. Factors associated with disease-specific life impact in patients with hidradenitis suppurativa: results from the Global VOICE project. Br J Dermatol. 2023 05 24; 188(6):808-810. Garg A, Rawal S, Akilov O, Alavi A, Ardon C, Bechara FG, Cohen AD, Cohen SR, Daveluy S, Del Marmol V, Delage M, Esmann S, Fisher S, Giamarellos-Bourboulis EJ, Glowaczewska A, Goldfarb N, Brant EG, Grimstad Ø, Guilbault S, Hamzavi I, Hughes R, Ingram JR, Jemec GBE, Ju Q, Kappe N, Kirby B, Kirby JS, Lowes MA, Matusiak L, Micha S, Micheletti RG, Miller AP, Moseng D, Naik HB, Nassif A, Nikolakis G, Paek SY, Pascual JC, Prens E, Resnik B, Riad H, Sayed C, Smith SD, Soliman Y, Szepietowski JC, Tan J, Thorlacius L, Tzellos T, van der Zee HH, Villumsen B, Wang L, Zouboulis CC, Strunk A. PMID: 36891871.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. Patient Perspectives of Health System Barriers to Accessing Care for Hidradenitis Suppurativa: A Qualitative Study. JAMA Dermatol. 2023 05 01; 159(5):510-517. Barnes LA, Shukla N, Paul M, de Vere Hunt I, Halley MC, Linos E, Naik HB. PMID: 37017984; PMCID: PMC10077133.
      View in: PubMed   Mentions: 1     Fields:    
    14. Tertiary Lymphoid Structures Sustain Cutaneous B cell Activity in Hidradenitis Suppurativa. bioRxiv. 2023 Feb 15. Lowe MM, Cohen JN, Moss MI, Clancy S, Adler J, Yates A, Naik HB, Pauli M, Taylor I, McKay A, Harris H, Kim E, Hansen SL, Rosenblum MD, Moreau JM. PMID: 36824918; PMCID: PMC9949072.
      View in: PubMed   Mentions:
    15. Real-World Findings on the Characteristics and Treatment Exposures of Patients with Hidradenitis Suppurativa from US Claims Data. Dermatol Ther (Heidelb). 2023 Feb; 13(2):581-594. Garg A, Naik HB, Alavi A, Hazen P, Hsiao JL, Shi VY, Weisman J, Tran T, Rudnik J, Jedrzejczyk A, Pansar I, Kimball AB. PMID: 36585607; PMCID: PMC9884733.
      View in: PubMed   Mentions: 2  
    16. Biologic Therapy Is Not Associated with Increased COVID-19 Severity in Patients with Hidradenitis Suppurativa: Updated Findings from the Global Hidradenitis Suppurativa COVID-19 Registry. Dermatology. 2023; 239(2):283-286. Williams JC, Alhusayen R, Guilbault S, Hills NK, Ingram JR, Kudlinski MV, Lowes MA, Marzano AV, Paul M, Villumsen B, Yannuzzi CA, Naik HB. PMID: 36566748; PMCID: PMC9808885.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    17. Evaluation of Hidradenitis Suppurativa Diagnostic Criteria in Pediatric Patients. JAMA Dermatol. 2022 12 01; 158(12):1404-1408. Kittler NW, Williams JC, Kudlinski MV, Lester J, Hills N, Abuabara K, Naik HB. PMID: 36287577; PMCID: PMC9607937.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    18. Hidradenitis suppurativa and sleep: a systematic review. Arch Dermatol Res. 2023 Jul; 315(5):1409-1415. Yeroushalmi S, Ildardashty A, Elhage KG, Chung M, Bartholomew E, Hakimi M, Tahir P, Naik HB, Bhutani T, Liao W. PMID: 36396891.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    19. Reply-Response to Anakinra for refractory pustular psoriasis: A phase II, open label, dose-escalation trial. J Am Acad Dermatol. 2023 Mar; 88(3):743-744. Naik HB, Cowen EW. PMID: 36370903.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    20. Immunopathogenesis of hidradenitis suppurativa and response to anti-TNF-α therapy. JCI Insight. 2022 10 24; 7(20). Lowe MM, Naik HB, Clancy S, Pauli M, Smith KM, Bi Y, Dunstan R, Gudjonsson JE, Paul M, Harris H, Kim E, Shin US, Ahn R, Liao W, Hansen SL, Rosenblum MD. PMID: 36278491; PMCID: PMC9744256.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    21. A Practical Guide for Primary Care Providers on Timely Diagnosis and Comprehensive Care Strategies for Hidradenitis Suppurativa. Am J Med. 2023 01; 136(1):42-53. Garg A, Naik HB, Kirby JS. PMID: 36252715.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    22. Anakinra for refractory pustular psoriasis: A phase II, open-label, dose-escalation trial. J Am Acad Dermatol. 2022 12; 87(6):1380-1383. Naik HB, Pichard DC, Schwartz DM, O'Brien M, Masciocchi M, Thompson J, Sen HN, Steinberg SM, Mitchell SA, de Jesus AA, McCalmont TH, Dey A, Rosenstein RK, Deng Z, Goldbach-Mansky R, Mehta NN, Cowen EW. PMID: 36116584; PMCID: PMC10673680.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    23. Factors associated with treatment satisfaction in patients with hidradenitis suppurativa: results from the Global VOICE project. Br J Dermatol. 2022 Dec; 187(6):927-935. Midgette B, Strunk A, Akilov O, Alavi A, Ardon C, Bechara FG, Cohen AD, Cohen S, Daveluy S, Del Marmol V, Delage M, Esmann S, Fisher S, Giamarellos-Bourboulis EJ, Glowaczewska A, Goldfarb N, Brant EG, Grimstad Ø, Guilbault S, Hamzavi I, Hughes R, Ingram JR, Jemec GBE, Ju Q, Kappe N, Kirby B, Kirby JS, Lowes MA, Matusiak L, Micha S, Micheletti R, Miller AP, Moseng D, Naik H, Nassif A, Nikolakis G, Paek SY, Pascual JC, Prens E, Resnik B, Riad H, Sayed C, Smith SD, Soliman Y, Szepietowski JC, Tan J, Thorlacius L, Tzellos T, van der Zee HH, Villumsen B, Wang L, Zouboulis C, Garg A. PMID: 36056741.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    24. Identification of Biomarkers and Critical Evaluation of Biomarker Validation in Hidradenitis Suppurativa: A Systematic Review. JAMA Dermatol. 2022 03 01; 158(3):300-313. Der Sarkissian S, Hessam S, Kirby JS, Lowes MA, Mintoff D, Naik HB, Ring HC, Chandran NS, Frew JW. PMID: 35044423; PMCID: PMC9131897.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    25. Diagnosing and Managing Hidradenitis Suppurativa in Pediatrics. Pediatr Ann. 2022 Mar; 51(3):e123-e127. Collier EK, Sachdeva M, Yazdani S, Hogeling M, Okun M, Naik HB, Lowes MA, Hsiao JL, Shi VY. PMID: 35293815.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    26. Guidance on COVID-19 Vaccination in Hidradenitis Suppurativa Patients: A Modified Delphi Consensus of Experts. Skin Appendage Disord. 2022 Jul; 8(4):287-290. Rick JW, De DR, Shih T, Alavi A, Kirby JS, Naik HB, Frew JW, Sayed CJ, Hsiao JL, Shi VY. PMID: 35979524; PMCID: PMC9274824.
      View in: PubMed   Mentions:
    27. Medical Management of Hidradenitis Suppurativa with Non-Biologic Therapy: What's New? Am J Clin Dermatol. 2022 Mar; 23(2):167-176. Ghanian S, Yamanaka-Takaichi M, Naik HB, Alavi A. PMID: 34990004; PMCID: PMC9131893.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    28. Evaluation of a Case Series of Patients With Palmoplantar Pustulosis in the United States. JAMA Dermatol. 2022 Jan 01; 158(1):68-72. Noe MH, Wan MT, Mostaghimi A, Gelfand JM, Pustular Psoriasis in the US Research Group, Agnihothri R, Armstrong AW, Bhutani T, Bridges A, Brownstone N, Butt M, Duffin KPC, Carr C, Creadore A, DeNiro KL, Desai S, Dominguez AR, Duffy EK, Fairley JA, Femia A, Gudjonsson JE, Kaffenberger JA, Katz KL, Kirby JS, Le ST, Martinez E, Maverakis E, Myers B, Naik HB, Nelson CA, Ortega-Loayza AG, Plovanich ME, Rangel LK, Ravi V, Reddy VD, Saleh JZ, Sandhu JK, Shakshouk H, Shields BE, Sharif-Sidi Z, Smith J, Steahr A, Toussi A, Wanat KA, Wang B, Wei BM, Weinhammer A, Worswick SD, Yang A. PMID: 34878495; PMCID: PMC8655660.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    29. Evaluation of a Case Series of Patients With Generalized Pustular Psoriasis in the United States. JAMA Dermatol. 2022 Jan 01; 158(1):73-78. Noe MH, Wan MT, Mostaghimi A, Gelfand JM, Pustular Psoriasis in the US Research Group, Agnihothri R, Armstrong AW, Bhutani T, Bridges A, Brownstone N, Butt M, Duffin KPC, Carr C, Creadore A, DeNiro KL, Desai S, Dominguez AR, Duffy EK, Fairley JA, Femia A, Gudjonsson JE, Kaffenberger JA, Katz KL, Le ST, Martinez E, Maverakis E, Myers B, Naik HB, Nelson CA, Ortega-Loayza AG, Plovanich ME, Rangel LK, Ravi V, Reddy VD, Saleh JZ, Kirby JS, Sandhu JK, Shakshouk H, Shields BE, Sharif-Sidi Z, Smith J, Steahr A, Toussi A, Wanat KA, Wang B, Wei BM, Weinhammer A, Worswick SD, Yang A. PMID: 34878491; PMCID: PMC8655659.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    30. Biologic therapy is not associated with increased COVID-19 severity in patients with hidradenitis suppurativa: Initial findings from the Global Hidradenitis Suppurativa COVID-19 Registry. J Am Acad Dermatol. 2022 01; 86(1):249-252. Naik HB, Alhusayen R, Frew J, Guilbault S, Hills NK, Ingram JR, Kudlinski MV, Lowes MA, Marzano AV, Paul M, Villumsen B, Yannuzzi CA. PMID: 34537252; PMCID: PMC8443529.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    31. Healthcare Resource Use in Patients with Immune-Mediated Conditions Treated with Targeted Immunomodulators During COVID-19 Pandemic: A Retrospective Claims Analysis. Adv Ther. 2021 10; 38(10):5302-5316. Bergman M, Saffore CD, Kim KJ, Patel PA, Garg V, Xuan S, Naik HB. PMID: 34515976; PMCID: PMC8436009.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCellsPHPublic Health
    32. Dermatology COVID-19 Registries: Updates and Future Directions. Dermatol Clin. 2021 Oct; 39(4):575-585. Freeman EE, Chamberlin GC, McMahon DE, Hruza GJ, Wall D, Meah N, Sinclair R, Balogh EA, Feldman SR, Lowes MA, Marzano AV, Naik HB, Castelo-Soccio L, Lara-Corrales I, Cordoro KM, Mahil SK, Griffiths CEM, Smith CH, Irvine AD, Spuls PI, Flohr C, French LE. PMID: 34556247; PMCID: PMC8165090.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    33. Learning from disease registries during a pandemic: Moving toward an international federation of patient registries. Clin Dermatol. 2021 May-Jun; 39(3):467-478. Wall D, Alhusayen R, Arents B, Apfelbacher C, Balogh EA, Bokhari L, Bloem M, Bosma AL, Burton T, Castelo-Soccio L, Fagan N, Feldman SR, Fletcher G, Flohr C, Freeman E, French LE, Griffiths CEM, Hruza GJ, Ingram JR, Kappelman MD, Lara-Corrales I, Lim HW, Meah N, McMahon DE, Mahil SK, McNicoll I, Musters A, Naik HB, Sinclair R, Smith CH, Spuls P, Tobin DJ, York K, Irvine AD. PMID: 34518006; PMCID: PMC8432911.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCellsPHPublic Health
    34. Hidradenitis Suppurativa in the Pediatric Population: An International, Multicenter, Retrospective, Cross-sectional Study of 481 Pediatric Patients. JAMA Dermatol. 2021 04 01; 157(4):385-391. Liy-Wong C, Kim M, Kirkorian AY, Eichenfield LF, Diaz LZ, Horev A, Tollefson M, Oranges T, Philips R, Chiu YE, Ghafari G, Arnold JD, Sprague J, Nguyen H, Wan S, Atenafu EG, Pope E, Hamilton J, Naik HB, Lara-Corrales I. PMID: 33625473; PMCID: PMC7905696.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    35. Expert Knowledge, Attitudes, and Practices in Management of Hidradenitis Suppurativa Pain. JAMA Dermatol. 2021 04 01; 157(4):464-466. Jedrzejczak MJ, Ingram JR, Lowes MA, Naik HB, McKenzie-Brown AM, Chen SC, Orenstein LAV. PMID: 33625467; PMCID: PMC7905694.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    36. Importance of Standardized Nomenclature to Advance Hidradenitis Suppurativa Research and Clinical Care. JAMA Dermatol. 2021 04 01; 157(4):381-383. Naik HB. PMID: 33688911; PMCID: PMC8163030.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    37. Quality and engagement of online hidradenitis suppurativa information. Int J Womens Dermatol. 2021 Sep; 7(4):490-491. Shukla NR, Jia JL, Paul M, Kaghazchi A, Linos E, Naik HB. PMID: 34621966; PMCID: PMC8484951.
      View in: PubMed   Mentions: 2  
    38. Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations. J Am Acad Dermatol. 2022 05; 86(5):1092-1101. Garg A, Malviya N, Strunk A, Wright S, Alavi A, Alhusayen R, Alikhan A, Daveluy SD, Delorme I, Goldfarb N, Gulliver W, Hamzavi I, Jaleel T, Kimball AB, Kirby JS, Kirchhof MG, Lester J, Lev-Tov H, Lowes MA, Micheletti R, Orenstein LA, Piguet V, Sayed C, Tan J, Naik HB. PMID: 33493574; PMCID: PMC8298595.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    39. Immunopathogenesis of hidradenitis suppurativa and response to anti-TNF-α therapy. JCI Insight. 2020 10 02; 5(19). Lowe MM, Naik HB, Clancy S, Pauli M, Smith KM, Bi Y, Dunstan R, Gudjonsson JE, Paul M, Harris H, Kim E, Shin US, Ahn R, Liao W, Hansen SL, Rosenblum MD. PMID: 32841223; PMCID: PMC7566733.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCells
    40. Diagnosis and management of hidradenitis suppurativa in women. Am J Obstet Gynecol. 2021 01; 224(1):54-61. Collier EK, Parvataneni RK, Lowes MA, Naik HB, Okun M, Shi VY, Hsiao JL. PMID: 32980357; PMCID: PMC8163033.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    41. Characterizing perimenstrual flares of hidradenitis suppurativa. Int J Womens Dermatol. 2020 Dec; 6(5):372-376. Collier EK, Price KN, Grogan TR, Naik HB, Shi VY, Hsiao JL. PMID: 33898701; PMCID: PMC8060664.
      View in: PubMed   Mentions: 6  
    42. Standardizing Hidradenitis Suppurativa Skin Microbiome Research: The Methods Matter. J Invest Dermatol. 2020 09; 140(9):1688-1690. Naik HB, Piguet V. PMID: 32800181; PMCID: PMC8186859.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    43. Global Hidradenitis Suppurativa COVID-19 Registry: a registry to inform data-driven management practices. Br J Dermatol. 2020 10; 183(4):780-781. Naik HB, Alhusayen R, Frew J, Guilbault S, Ingram JR, Lowes MA, Marzano AV, Paul M, Villumsen B, Yannuzzi CA. PMID: 32597495; PMCID: PMC7361290.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCellsPHPublic Health
    44. Remote management of hidradenitis suppurativa in a pandemic era of COVID-19. Int J Dermatol. 2020 Sep; 59(9):e318-e320. Kang NC, Hsiao J, Shi V, Naik HB, Lowes MA, Alavi A. PMID: 32578210; PMCID: PMC7361922.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCellsPHPublic Health
    45. International collaboration and rapid harmonization across dermatologic COVID-19 registries. J Am Acad Dermatol. 2020 09; 83(3):e261-e266. Freeman EE, McMahon DE, Hruza GJ, Irvine AD, Spuls PI, Smith CH, Mahil SK, Castelo-Soccio L, Cordoro KM, Lara-Corrales I, Naik HB, Alhusayen R, Ingram JR, Feldman SR, Balogh EA, Kappelman MD, Wall D, Meah N, Sinclair R, Beylot-Barry M, Fitzgerald M, French LE, Lim HW, Griffiths CEM, Flohr C. PMID: 32562840; PMCID: PMC7833847.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCellsPHPublic Health
    46. Hidradenitis suppurativa publications are sparse in frontline specialties. Br J Dermatol. 2020 10; 183(4):770-771. Martins DB, Ayanruoh L, Paul M, Shukla N, Naik HB. PMID: 32294228; PMCID: PMC8174654.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    47. Retrospective cohort study of pregnancy outcomes in hidradenitis suppurativa. Br J Dermatol. 2020 11; 183(5):945-947. Lyons AB, Peacock A, McKenzie SA, Jacobsen G, Naik HB, Shi VY, Hamzavi IH, Hsiao JL. PMID: 32333790; PMCID: PMC8174655.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    48. Evaluation of Hidradenitis Suppurativa Disease Course During Pregnancy and Postpartum. JAMA Dermatol. 2020 06 01; 156(6):681-685. Lyons AB, Peacock A, McKenzie SA, Jacobsen G, Naik HB, Shi VY, Hamzavi IH, Hsiao JL. PMID: 32347884; PMCID: PMC7191431.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    49. Office-Based Surgical Intervention for Hidradenitis Suppurativa (HS): A Focused Review for Dermatologists. Dermatol Ther (Heidelb). 2020 Aug; 10(4):529-549. Saylor DK, Brownstone ND, Naik HB. PMID: 32435998; PMCID: PMC7367977.
      View in: PubMed   Mentions: 2  
    50. The Asia Pacific Hidradenitis Suppurativa (APHiS) foundation: promoting hidradenitis suppurativa research in the Asia Pacific. Int J Dermatol. 2020 Aug; 59(8):e289-e290. Kamil MAA, Chandran NS, Sulistyaningrum SK, Rajagopalan M, Tahiliani S, Hsiao J, Naik H, Shi V, Frew JW. PMID: 32436230; PMCID: PMC8174653.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    51. Hidradenitis suppurativa: The importance of virtual outpatient care during COVID-19 pandemic. J Am Acad Dermatol. 2020 07; 83(1):e81-e82. Shah M, Naik HB, Alhusayen R. PMID: 32360857; PMCID: PMC7252061.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCellsPHPublic Health
    52. Comprehensive approach to managing hidradenitis suppurativa patients. Int J Dermatol. 2020 Jun; 59(6):744-747. Collier EK, Hsiao JL, Shi VY, Naik HB. PMID: 32250448; PMCID: PMC8310652.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    53. Creation of a Registry to Address Knowledge Gaps in Hidradenitis Suppurativa and Pregnancy-Reply. JAMA Dermatol. 2020 03 01; 156(3):354. Naik HB, Lowes MA. PMID: 31913415; PMCID: PMC8186858.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    54. Identifying barriers to care and research in hidradenitis suppurativa: findings from a patient engagement event. Br J Dermatol. 2020 06; 182(6):1490-1492. Shukla N, Paul M, Halley M, Lowes MA, Hester V, Aguilar C, Guilbault S, Long TS, Taylor A, Thompson AC, Yannuzzi CA, Linos E, Naik HB. PMID: 31883104; PMCID: PMC7266711.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    55. Hidradenitis suppurativa encounters in a national electronic health record database notable for low dermatology utilization, infrequent biologic prescriptions, and frequent opiate prescriptions. J Am Acad Dermatol. 2020 05; 82(5):1239-1241. Wehner MR, Micheletti R, Noe MH, Linos E, Margolis DJ, Naik HB. PMID: 31866261; PMCID: PMC6980686.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    56. Combined cancer patient-reported symptom and health utility tool for routine clinical implementation: a real-world comparison of the ESAS and EQ-5D in multiple cancer sites. Curr Oncol. 2019 12; 26(6):e733-e741. Moskovitz M, Jao K, Su J, Brown MC, Naik H, Eng L, Wang T, Kuo J, Leung Y, Xu W, Mittmann N, Moody L, Barbera L, Devins G, Li M, Howell D, Liu G. PMID: 31896943; PMCID: PMC6927786.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    57. Skin Microbiota Perturbations Are Distinct and Disease Severity-Dependent in Hidradenitis Suppurativa. J Invest Dermatol. 2020 04; 140(4):922-925.e3. Naik HB, Jo JH, Paul M, Kong HH. PMID: 31539533; PMCID: PMC7075718.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    58. Hidradenitis Suppurativa Area and Severity Index (HASI): a pilot study to develop a novel instrument to measure the physical signs of hidradenitis suppurativa. Br J Dermatol. 2020 01; 182(1):240-242. Goldfarb N, Ingram JR, Jemec GBE, Naik HB, Piguet V, Hyde MJ, Freese R, Lowes MA, Alavi A. PMID: 31286486; PMCID: PMC7769071.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    59. A Call to Accelerate Hidradenitis Suppurativa Research and Improve Care-Moving Beyond Burden. JAMA Dermatol. 2019 Sep 01; 155(9):1005-1006. Naik HB, Lowes MA. PMID: 31290934; PMCID: PMC9131891.
      View in: PubMed   Mentions: 11     Fields:    
    60. Defining lesional, perilesional and unaffected skin in hidradenitis suppurativa: proposed recommendations for clinical trials and translational research studies. Br J Dermatol. 2019 12; 181(6):1339-1341. Frew JW, Navrazhina K, Byrd AS, Garg A, Ingram JR, Kirby JS, Lowes MA, Naik H, Piguet V, Prens EP. PMID: 31269228; PMCID: PMC9131889.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    61. Gender Equity Improving among Award Winners and Leaders at the Society for Investigative Dermatology. J Invest Dermatol. 2019 10; 139(10):2215-2217. Shukla N, Wehner MR, Morrison L, Naik HB, Linos E. PMID: 31445922; PMCID: PMC6952212.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    62. Specimen Collection for Translational Studies in Hidradenitis Suppurativa. Sci Rep. 2019 08 21; 9(1):12207. Byrd AS, Dina Y, Okoh UJ, Quartey QQ, Carmona-Rivera C, Williams DW, Kerns ML, Miller RJ, Petukhova L, Naik HB, Barnes LA, Shipman WD, Caffrey JA, Sacks JM, Milner SM, Aliu O, Broderick KP, Kim D, Liu H, Dillen CA, Ahn R, Frew JW, Kaplan MJ, Kang S, Garza LA, Miller LS, Alavi A, Lowes MA, Okoye GA. PMID: 31434914; PMCID: PMC6704132.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    63. Distribution of Self-reported Hidradenitis Suppurativa Age at Onset. JAMA Dermatol. 2019 Aug 01; 155(8):971-973. Naik HB, Paul M, Cohen SR, Alavi A, Suàrez-Fariñas M, Lowes MA. PMID: 31166574; PMCID: PMC6551578.
      View in: PubMed   Mentions: 9     Fields:    
    64. Evaluating patients' unmet needs in hidradenitis suppurativa: Results from the Global Survey Of Impact and Healthcare Needs (VOICE) Project. J Am Acad Dermatol. 2020 Feb; 82(2):366-376. Garg A, Neuren E, Cha D, Kirby JS, Ingram JR, Jemec GBE, Esmann S, Thorlacius L, Villumsen B, Marmol VD, Nassif A, Delage M, Tzellos T, Moseng D, Grimstad Ø, Naik H, Micheletti R, Guilbault S, Miller AP, Hamzavi I, van der Zee H, Prens E, Kappe N, Ardon C, Kirby B, Hughes R, Zouboulis CC, Nikolakis G, Bechara FG, Matusiak L, Szepietowski J, Glowaczewska A, Smith SD, Goldfarb N, Daveluy S, Avgoustou C, Giamarellos-Bourboulis E, Cohen S, Soliman Y, Brant EG, Akilov O, Sayed C, Tan J, Alavi A, Lowes MA, Pascual JC, Riad H, Fisher S, Cohen A, Paek SY, Resnik B, Ju Q, Wang L, Strunk A. PMID: 31279015.
      View in: PubMed   Mentions: 57     Fields:    Translation:Humans
    65. The associations of depression and coping methods on health-related quality of life for those with hidradenitis suppurativa. J Am Acad Dermatol. 2019 Apr; 80(4):1137-1139. Butt M, Sisic M, Silva C, Naik HB, Esmann S, Jemec G, Kirby JS. PMID: 30876533.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    66. North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part II: Topical, intralesional, and systemic medical management. J Am Acad Dermatol. 2019 Jul; 81(1):91-101. Alikhan A, Sayed C, Alavi A, Alhusayen R, Brassard A, Burkhart C, Crowell K, Eisen DB, Gottlieb AB, Hamzavi I, Hazen PG, Jaleel T, Kimball AB, Kirby J, Lowes MA, Micheletti R, Miller A, Naik HB, Orgill D, Poulin Y. PMID: 30872149; PMCID: PMC9131892.
      View in: PubMed   Mentions: 64     Fields:    Translation:Humans
    67. North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part I: Diagnosis, evaluation, and the use of complementary and procedural management. J Am Acad Dermatol. 2019 Jul; 81(1):76-90. Alikhan A, Sayed C, Alavi A, Alhusayen R, Brassard A, Burkhart C, Crowell K, Eisen DB, Gottlieb AB, Hamzavi I, Hazen PG, Jaleel T, Kimball AB, Kirby J, Lowes MA, Micheletti R, Miller A, Naik HB, Orgill D, Poulin Y. PMID: 30872156; PMCID: PMC9131894.
      View in: PubMed   Mentions: 82     Fields:    Translation:Humans
    68. Gender Equity in Clinical Dermatology-Reason for Optimism. JAMA Dermatol. 2019 03 01; 155(3):284-286. Wehner MR, Naik HB, Linos E. PMID: 30725081; PMCID: PMC6682421.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    69. Proceeding report of the Second Symposium on Hidradenitis Suppurativa Advances (SHSA) 2017. Exp Dermatol. 2019 01; 28(1):94-103. Shavit E, Alavi A, Bechara FG, Bennett RG, Bourcier M, Cibotti R, Daveluy S, Frew JW, Garg A, Hamzavi I, Hoffman LK, Hsaio J, Kirby JS, Lev-Tov H, Martinez E, Micheletti R, Naik HB, Nassif A, Nicholson C, Parks-Miller A, Patel Z, Piguet V, Ramesh M, Resnik B, Sayed C, Schultz G, Siddiqui A, Tan J, Wortsman X, Lowes MA. PMID: 30484907; PMCID: PMC6600821.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    70. The TNFRSF members CD27 and OX40 coordinately limit TH17 differentiation in regulatory T cells. Sci Immunol. 2018 12 21; 3(30). Remedios KA, Zirak B, Sandoval PM, Lowe MM, Boda D, Henley E, Bhattrai S, Scharschmidt TC, Liao W, Naik HB, Rosenblum MD. PMID: 30578350.
      View in: PubMed   Mentions: 21     Fields:    Translation:AnimalsCells
    71. Health utility scores from EQ-5D and health-related quality of life in patients with esophageal cancer: a real-world cross-sectional study. Dis Esophagus. 2018 Dec 01; 31(12). Doherty MK, Leung Y, Su J, Naik H, Patel D, Eng L, Kong QQ, Mohsin F, Brown MC, Espin-Garcia O, Vennettilli A, Renouf DJ, Faluyi OO, Knox JJ, MacKay H, Wong R, Howell D, Mittmann N, Darling GE, Cella D, Xu W, Liu G. PMID: 29905764.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    72. Are Bacteria Infectious Pathogens in Hidradenitis Suppurativa? Debate at the Symposium for Hidradenitis Suppurativa Advances Meeting, November 2017. J Invest Dermatol. 2019 01; 139(1):13-16. Naik HB, Nassif A, Ramesh MS, Schultz G, Piguet V, Alavi A, Lowes MA. PMID: 30414909; PMCID: PMC8171295.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    73. Perspective From the 5th International Pemphigus and Pemphigoid Foundation Scientific Conference. Front Med (Lausanne). 2018; 5:306. Lee J, Werth VP, Hall RP, Eming R, Fairley JA, Fajgenbaum DC, Harman KE, Jonkman MF, Korman NJ, Ludwig RJ, Murrell DF, Musette P, Naik HB, Sadik CD, Yamagami J, Yale ML, Payne AS. PMID: 30467542; PMCID: PMC6236000.
      View in: PubMed   Mentions: 13  
    74. The effect of antimicrobial washes on antibacterial resistance in hidradenitis suppurativa lesions. J Am Acad Dermatol. 2019 03; 80(3):821-822. Leiphart P, Ma H, Naik HB, Kirby JS. PMID: 30403961.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    75. Concurrent anticytokine biologics for the management of severe hidradenitis suppurativa: are they safe and effective? Cutis. 2018 03; 101(3):163;164;176. Naik HB, McGinness A, Shinkai K. PMID: 29718020.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    76. Systematic reviews of case reports and case series: from anecdote to evidence. Br J Dermatol. 2018 02; 178(2):317-318. Naik HB, Abuabara K. PMID: 29441546.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    77. Successful treatment of mucous membrane pemphigoid with bortezomib. JAAD Case Rep. 2018 Jan; 4(1):81-83. Saeed L, Schmidt TH, Gensler LS, Gross AJ, Fox LP, Scharschmidt TC, Gaensler K, Naik H, Rosenblum MA, Shinkai K. PMID: 29387757; PMCID: PMC5771728.
      View in: PubMed   Mentions: 2  
    78. A pilot study comparing histological and immunophenotypic patterns in stage 4 skin graft vs host disease from toxic epidermal necrolysis. J Cutan Pathol. 2017 Oct; 44(10):857-860. Naik H, Lockwood S, Saavedra A. PMID: 28626936.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    79. Hidradenitis suppurativa, introduction. Semin Cutan Med Surg. 2017 Jun; 36(2):41. Naik HB. PMID: 28538741.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    80. Complications of hidradenitis suppurativa. Semin Cutan Med Surg. 2017 Jun; 36(2):79-85. Yuan JT, Naik HB. PMID: 28538749.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    81. Upregulation of IFN-Inducible and Damage-Response Pathways in Chronic Graft-versus-Host Disease. J Immunol. 2016 11 01; 197(9):3490-3503. Hakim FT, Memon S, Jin P, Imanguli MM, Wang H, Rehman N, Yan XY, Rose J, Mays JW, Dhamala S, Kapoor V, Telford W, Dickinson J, Davis S, Halverson D, Naik HB, Baird K, Fowler D, Stroncek D, Cowen EW, Pavletic SZ, Gress RE. PMID: 27694491; PMCID: PMC5101132.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCellsCTClinical Trials
    82. Severity of Psoriasis Associates With Aortic Vascular Inflammation Detected by FDG PET/CT and Neutrophil Activation in a Prospective Observational Study. Arterioscler Thromb Vasc Biol. 2015 Dec; 35(12):2667-76. Naik HB, Natarajan B, Stansky E, Ahlman MA, Teague H, Salahuddin T, Ng Q, Joshi AA, Krishnamoorthy P, Dave J, Rose SM, Doveikis J, Playford MP, Prussick RB, Ehrlich A, Kaplan MJ, Lockshin BN, Gelfand JM, Mehta NN. PMID: 26449753; PMCID: PMC4662627.
      View in: PubMed   Mentions: 91     Fields:    Translation:HumansCells
    83. Efficacy of Intralesional Botulinum Toxin A for Treatment of Painful Cutaneous Leiomyomas: A Randomized Clinical Trial. JAMA Dermatol. 2015 Oct; 151(10):1096-102. Naik HB, Steinberg SM, Middelton LA, Hewitt SM, Zuo RC, Linehan WM, Kong HH, Cowen EW. PMID: 26244563; PMCID: PMC7712636.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    84. Oral disease profiles in chronic graft versus host disease. J Dent Res. 2015 Apr; 94(4):547-54. Bassim CW, Fassil H, Mays JW, Edwards D, Baird K, Steinberg SM, Cowen EW, Naik H, Datiles M, Stratton P, Gress RE, Pavletic SZ. PMID: 25740857; PMCID: PMC4485216.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    85. Risk factors and characterization of vitiligo and alopecia areata in patients with chronic graft-vs-host disease. JAMA Dermatol. 2015 Jan; 151(1):23-32. Zuo RC, Naik HB, Steinberg SM, Baird K, Mitchell SA, Kuzmina Z, Pavletic SZ, Cowen EW. PMID: 25207994; PMCID: PMC7703696.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    86. Clinical significance of autoantibodies in a large cohort of patients with chronic graft-versus-host disease defined by NIH criteria. Am J Hematol. 2015 Feb; 90(2):114-9. Kuzmina Z, Gounden V, Curtis L, Avila D, Rnp TT, Baruffaldi J, Cowen EW, Naik HB, Hasni SA, Mays JW, Mitchell S, Baird K, Steinberg SM, Pavletic SZ. PMID: 25363867; PMCID: PMC5535796.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCellsCTClinical Trials
    87. Characterization of immune cells in psoriatic adipose tissue. J Transl Med. 2014 Sep 16; 12:258. Rose S, Stansky E, Dagur PK, Samsel L, Weiner E, Jahanshad A, Doveikis J, Naik HB, Playford MP, McCoy JP, Mehta NN. PMID: 25224267; PMCID: PMC4197293.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    88. Prevalence of isolated joint involvement in chronic graft-versus-host disease: comment on the article by Inamoto et al. Arthritis Rheumatol. 2014 Sep; 66(9):2646-8. Kuzmina Z, Joe GO, Baird K, Cowen EW, Naik HB, Steinberg SM, Curtis L, Comis LE, Pavletic SZ. PMID: 24819543; PMCID: PMC4212407.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    89. Palmoplantar pustules and osteoarticular pain in a 42-year-old woman. J Am Acad Dermatol. 2015 Mar; 72(3):550-3. Zuo RC, Schwartz DM, Lee CC, Anadkat MJ, Cowen EW, Naik HB. PMID: 25127881; PMCID: PMC4326625.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    90. Psoriatic arthritis and sacroiliitis are associated with increased vascular inflammation by 18-fluorodeoxyglucose positron emission tomography computed tomography: baseline report from the Psoriasis Atherosclerosis and Cardiometabolic Disease Initiative. Arthritis Res Ther. 2014 Jul 30; 16(4):R161. Rose S, Dave J, Millo C, Naik HB, Siegel EL, Mehta NN. PMID: 25078679; PMCID: PMC4261785.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    91. IL-17A production in human psoriatic blood and lesions by CD146+ T cells. J Invest Dermatol. 2015 Jan; 135(1):311-314. Mehta NN, Dagur PK, Rose SM, Naik HB, Stansky E, Doveikis J, Biancotto A, Playford MP, Philip McCoy J. PMID: 25058615; PMCID: PMC4267954.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    92. Autoinflammatory pustular neutrophilic diseases. Dermatol Clin. 2013 Jul; 31(3):405-25. Naik HB, Cowen EW. PMID: 23827244; PMCID: PMC3703099.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCells
    93. Diabetes insipidus, bone lesions, and new-onset red-brown papules in a 42-year-old man. J Am Acad Dermatol. 2013 Jun; 68(6):1034-8. Kornik RI, Naik HB, Lee CC, Estrada-Veras J, Gahl WA, Cowen EW. PMID: 23466246; PMCID: PMC3657338.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    94. Epidemiological trends of leprosy in an urban leprosy centre of Delhi: a retrospective study of 16 years. Indian J Lepr. 2011 Oct-Dec; 83(4):201-8. Tiwary PK, Kar HK, Sharma PK, Gautam RK, Arora TC, Naik H, Dhir V. PMID: 22783754.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic Health
    95. Pyoderma gangrenosum presenting with leukemoid reaction: a report of 2 cases. Arch Dermatol. 2010 May; 146(5):568-9. Ryu J, Naik H, Yang FC, Winterfield L. PMID: 20479317.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    96. Monochloramine-induced toxicity and dysregulation of intracellular Zn2+ in parietal cells of rabbit gastric glands. Am J Physiol Gastrointest Liver Physiol. 2010 Jul; 299(1):G170-8. Kohler JE, Dubach JM, Naik HB, Tai K, Blass AL, Soybel DI. PMID: 20430873; PMCID: PMC2904116.
      View in: PubMed   Mentions: 8     Fields:    Translation:AnimalsCells
    97. Secretory state regulates Zn2+ transport in gastric parietal cell of the rabbit. Am J Physiol Cell Physiol. 2009 Oct; 297(4):C979-89. Naik HB, Beshire M, Walsh BM, Liu J, Soybel DI. PMID: 19675302; PMCID: PMC2770737.
      View in: PubMed   Mentions: 8     Fields:    Translation:AnimalsCells
    98. Chemotherapeutic agents and the skin: An update. J Am Acad Dermatol. 2008 Apr; 58(4):545-70. Heidary N, Naik H, Burgin S. PMID: 18342708.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansCells
    99. Thiol-oxidant monochloramine mobilizes intracellular Ca2+ in parietal cells of rabbit gastric glands. Am J Physiol Cell Physiol. 2007 Nov; 293(5):C1687-97. Walsh BM, Naik HB, Dubach JM, Beshire M, Wieland AM, Soybel DI. PMID: 17287368.
      View in: PubMed   Mentions: 8     Fields:    Translation:AnimalsCells
    100. Impaired recognition of apoptotic neutrophils by the C1q/calreticulin and CD91 pathway in systemic lupus erythematosus. Arthritis Rheum. 2006 May; 54(5):1543-56. Donnelly S, Roake W, Brown S, Young P, Naik H, Wordsworth P, Isenberg DA, Reid KB, Eggleton P. PMID: 16645988.
      View in: PubMed   Mentions: 56     Fields:    Translation:HumansCells
    101. Delineation of a minimal interval and identification of 9 candidates for a tumor suppressor gene in malignant myeloid disorders on 5q31. Blood. 2000 Apr 01; 95(7):2372-7. Horrigan SK, Arbieva ZH, Xie HY, Kravarusic J, Fulton NC, Naik H, Le TT, Westbrook CA. PMID: 10733509.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    102. A phase II trial of oral estramustine and oral etoposide in hormone refractory prostate cancer. Urology. 1997 Sep; 50(3):401-6; discussion 406-7. Pienta KJ, Redman BG, Bandekar R, Strawderman M, Cease K, Esper PS, Naik H, Smith DC. PMID: 9301705.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    Haley's Networks
    Concepts (385)
    Derived automatically from this person's publications.
    _
    Co-Authors (32)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _